Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Delcasertib

Next Previous
X
Search
Drug Profile

Delcasertib

Alternative Names: BMS-875944; CS-9803; KAI-9803; KID1-1

Latest Information Update: 31 Jul 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator KAI Pharmaceuticals
  • Class Cardiovascular therapies; Peptides
  • Mechanism of Action Protein kinase C delta inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Reperfusion injury; Stroke

Most Recent Events

  • 05 Jul 2012 KAI Pharmaceuticals has been acquired by Amgen
  • 30 Aug 2011 KAI Pharmaceuticals completes a phase IIb trial in Reperfusion injuries in Europe, North America, Israel, New Zealand, and Australia (NCT00785954)
  • 05 Apr 2011 Efficacy data from the phase II PROTECTION-AMI trial in Reperfusion injury presented at the 60th Annual Scientific Session of the American College of Cardiology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top